Arbutus Biopharma (STU:I9DN) ROE % Adjusted to Book Value : -16.11% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma ROE % Adjusted to Book Value?

Arbutus Biopharma's ROE % for the quarter that ended in Mar. 2024 was -64.91%. Arbutus Biopharma's PB Ratio for the quarter that ended in Mar. 2024 was 4.03. Arbutus Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -16.11%.

Arbutus Biopharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Arbutus Biopharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma ROE % Adjusted to Book Value Chart

Arbutus Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-17.03

-18.21

-15.05

Arbutus Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.70	-18.07	-23.04	-17.29	-16.11

Competitive Comparison of Arbutus Biopharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Arbutus Biopharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arbutus Biopharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arbutus Biopharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arbutus Biopharma's ROE % Adjusted to Book Value falls into.

Arbutus Biopharma ROE % Adjusted to Book Value Calculation

Arbutus Biopharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-59.01%	/	3.92
	=	-15.05%

Arbutus Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-64.91%	/	4.03
	=	-16.11%

Arbutus Biopharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbutus Biopharma (STU:I9DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (STU:I9DN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ABUS:USA

Address

701 Veterans Circle, Warminster, PA, USA, 18974

Website

http://www.arbutusbio.com

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma (STU:I9DN) Headlines

No Headlines